{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:00:31Z","timestamp":1777503631359,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.xphs.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T02:45:12Z","timestamp":1520477112000},"page":"1806-1819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Analytical Comparability Assessments of 5 Recombinant CRM 197 Proteins From Different Manufacturers and Expression Systems"],"prefix":"10.1016","volume":"107","author":[{"given":"John M.","family":"Hickey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal M.","family":"Toprani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawaljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi P.N.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Oganesyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sitrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Volkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2012.03943.x","article-title":"A\u00a0century of pneumococcal vaccination research in humans","volume":"18 Suppl 5","author":"Grabenstein","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.xphs.2018.03.002_bib2","series-title":"Understanding Modern Vaccines: Perspectives in Vaccinology","first-page":"61","article-title":"Vaccine antigens","author":"Strugnell","year":"2011"},{"issue":"27","key":"10.1016\/j.xphs.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jchromb.2016.04.001","article-title":"Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms","volume":"1032","author":"Hickey","year":"2016","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"10","key":"10.1016\/j.xphs.2018.03.002_bib5","first-page":"50","article-title":"Carrier protein outsourcing: a new paradigm for rapidly translating novel conjugate vaccines into the clinic","volume":"10","author":"Brady","year":"2012","journal-title":"BioProcess Int"},{"issue":"9789","key":"10.1016\/j.xphs.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(11)60406-6","article-title":"The future of immunisation policy, implementation, and financing","volume":"378","author":"Levine","year":"2011","journal-title":"Lancet"},{"issue":"31","key":"10.1016\/j.xphs.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2018.03.002_bib8","doi-asserted-by":"crossref","unstructured":"Goffin P, Dewerchin M, De Rop P, Blais N, Dehottay P. High-yield production of recombinant CRM197, a non-toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli. Biotechnol J. [Epub ahead of print] 2017.","DOI":"10.1002\/biot.201700168"},{"issue":"4","key":"10.1016\/j.xphs.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02886955","article-title":"Secretory expression of recombinant diphtheria toxin mutants in B. subtilis","volume":"19","author":"Zhou","year":"1999","journal-title":"J\u00a0Tongji Med Univ"},{"issue":"4","key":"10.1016\/j.xphs.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals"},{"issue":"14","key":"10.1016\/j.xphs.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2018.03.002_bib12","series-title":"Vaccine Analysis: Strategies, Principles, and Control","first-page":"301","article-title":"Glycoconjugate vaccines","author":"Ravenscroft","year":"2015"},{"issue":"7","key":"10.1016\/j.xphs.2018.03.002_bib13","first-page":"1808","article-title":"Factors contributing to the immunogenicity of meningococcal conjugate vaccines","volume":"12","author":"Broker","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.xphs.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.xphs.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/elps.201300386","article-title":"Use of imaged capillary isoelectric focusing technique in development of diphtheria toxin mutant CRM197","volume":"35","author":"Rustandi","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.xphs.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ab.2017.06.013","article-title":"Quantitation of CRM197 using imaged capillary isoelectric focusing with fluorescence detection and capillary Western","volume":"534","author":"Loughney","year":"2017","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jps.22350","article-title":"Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies","volume":"100","author":"Gibson","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.xphs.2016.05.021","article-title":"A\u00a0micro-polyethylene glycol precipitation assay as a relative solubility screening tool for monoclonal antibody design and formulation development","volume":"105","author":"Toprani","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/jps.22618","article-title":"Multidimensional methods for the formulation of biopharmaceuticals and vaccines","volume":"100","author":"Maddux","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/pro.2144","article-title":"Improved data visualization techniques for analyzing macromolecule structural changes","volume":"21","author":"Kim","year":"2012","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(02)00223-1","article-title":"Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models","volume":"95","author":"Giraldo","year":"2002","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"e20176","DOI":"10.1371\/journal.pone.0020176","article-title":"Expression and purification of recombinant hemoglobin in Escherichia coli","volume":"6","author":"Natarajan","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.xphs.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1110\/ps.04679104","article-title":"Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase","volume":"13","author":"Liao","year":"2004","journal-title":"Protein Sci"},{"issue":"11","key":"10.1016\/j.xphs.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/js980069t","article-title":"Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone","volume":"87","author":"Costantino","year":"1998","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/pr800858h","article-title":"A\u00a0perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease","volume":"8","author":"Zhang","year":"2009","journal-title":"J\u00a0Proteome Res"},{"issue":"12","key":"10.1016\/j.xphs.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1016\/j.xphs.2017.07.019","article-title":"Structural characterization and physicochemical stability profile of a double mutant heat labile toxin protein based adjuvant","volume":"106","author":"Toprani","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fphar.2014.00039","article-title":"Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles","volume":"5","author":"Alsenaidy","year":"2014","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.xphs.2015.10.014","article-title":"Correlating the impact of well-defined oligosaccharide structures on physical stability profiles of IgG1-Fc glycoforms","volume":"105","author":"More","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.xphs.2015.10.013","article-title":"Biosimilarity assessments of model IgG1-Fc glycoforms using a machine learning approach","volume":"105","author":"Kim","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/febs.12783","article-title":"Diphtheria toxin conformational switching at acidic pH","volume":"281","author":"Leka","year":"2014","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.xphs.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2012.10.001","article-title":"Analytical lessons learned from selected therapeutic protein drug comparability studies","volume":"41","author":"Federici","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.xphs.2018.03.002_bib32","unstructured":"Lees A, Oganesyan N, Krauss I, Nguyen D. EcoCRMTM: affordable CRM197 vaccine Carrier protein. Poster Presented at: Protein Engineering Summit, Boston, MA, May 1\u00a02017."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918301400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918301400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T09:26:13Z","timestamp":1570872373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918301400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0022354918301400"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.03.002","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical Comparability Assessments of 5 Recombinant CRM197 Proteins From Different Manufacturers and Expression Systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}